Conserved polypeptides of Plasmodium falciparum as malaria vaccine candidates?
1991
S Herrera, and
M A Herrera, and
C Clavijo, and
A Corredor, and
U Certa
Department of Microbiology, School of Health, Universidad del Valle, Cali, Colombia.
UI
MeSH Term
Description
Entries
D008288
Malaria
A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.
A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics.
Plasmodium falciparums,falciparums, Plasmodium
D000818
Animals
Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.
Animal,Metazoa,Animalia
D000953
Antigens, Protozoan
Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered.
Protozoan Antigens
D016052
Protozoan Vaccines
Suspensions of attenuated or killed protozoa administered for the prevention or treatment of infectious protozoan disease.
Vaccines, Protozoan
Related Publications
S Herrera, and
M A Herrera, and
C Clavijo, and
A Corredor, and
U Certa